Earmarked funding – call 2023.1
Disruptive innovations happen when different technology sectors join forces.
In 2022 MEDVIA – supported by VLAIO – will provide €8 million in earmarked, non-dilutive funding for innovations in biotechnology, medical technology, and digital health technology.
The projects – combining at least two of the above sectors – should develop disruptive solutions for a clearly defined unmet need in healthcare or pool their research specialties to gain knowledge that will lead to such solutions. The results need to lead to a quantifiable increase in investment and employment in Flanders.
Your project should connect with one of our four overarching themes: Value-based healthcare, personalized medicine, digital medicine or disruptive health solutions.
Download the PDF document for more details. Additional documentation is available below.
The deadline for abstract submission is 23 February at noon. Click here for additional dates associated with the call.
Send download link to:
Templates full proposal
We opened four different VLAIO grant schemes:
We help you succeed.
MEDVIA assists participants with the preparation of their proposal. Of course, all participants bear full and final responsibility for writing and preparing a proposal that meets the criteria set by VLAIO for the respective grant schemes.
Interested in our future calls?